Cowen analyst Ken Cacciatore lowered his price target on Otonomy (NASDAQ: OTIC) to $9.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Piper Jaffray Downgrades Otonomy (OTIC) to NeutralAugust 30, 2017 11:23 AM JPMorgan Downgrades Otonomy (OTIC ) to NeutralAugust 30, 2017 9:42 AM Pre-Open Stock Movers 08/30: (VRA) (MZOR) (HIMX) Higher; (OTIC) (DY) (CHS) Lower (more...)August 30, 2017 9:22 AM UPDATE: Otonomy (OTIC) Plunges Over 77% After Phase 3 Trial of OTIVIDEX FailsAugust 30, 2017 7:33 AM Otonomy (OTIC) to Resume Trading at 7:30 AM ETAugust 30, 2017 7:25 AM Otonomy (OTIC) Says AVERTS-1 Phase 3 Trial for OTIVIDEX Missed Primary EndpointAugust 30, 2017 7:02 AM Form 8-K OTONOMY, INC. For: Aug 30August 30, 2017 7:01 AM Otonomy Reports Results for AVERTS-1 Phase 3 Trial for OTIVIDEX™ in Patients with Ménière's DiseaseAugust 30, 2017 7:00 AM Otonomy (OTIC) Halted, News PendingAugust 30, 2017 6:57 AM